Skip to main content

Autoantibodies to Argonaute 2 (Su Antigen)

  • Chapter
  • First Online:
Ten Years of Progress in GW/P Body Research

Abstract

Like many other classical autoantibodies in systemic rheumatic diseases, anti-Su antibodies were originally defined by the double immunodiffusion assay in the early 80s. However, despite its high prevalence, only a few reports on anti-Su were published in the following years and the progress in characterizing the target antigens and clinical significance was slow, probably due to its inconsistent or poor reactivity in other standard immunoassays. In 2006 the target antigen was identified as the microRNA (miRNA)-binding protein Argonaute 2 (Ago2). Ago2 is a key component of the RNA-induced silencing complex enriched in cytoplasmic foci called GW bodies. Due to preferential reactivity of human autoantibodies with native antigens, immunoprecipitation is the only method to reliably detect anti-Su/Ago2 antibodies. Anti-Su/Ago2 does not appear to have disease specificity since it is found in 10–20% of patients with various rheumatic diseases, including systemic lupus erythematosus, scleroderma, polymyositis/dermatomyositis, and Sjögren’s syndrome, as well as apparently healthy individuals at lower prevalence. The clinical significance and the mechanism of production of anti-Su/Ago2 remains to be clarified.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Azucena Palafox-Sanchez C, Satoh M, Chan EK, Carcamo WC, Francisco Munoz-Valle J, Orozco-Barocio G, Oregon Romero E, Elena Navarro Hernandez R, Salazar-Paramo M, Cabral Castaneda A, Vazquez-Del Mercado M (2009) Reduced IgG anti-small nuclear ribonucleoproteins autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies. Arthritis Res Ther 11:R27

    Article  Google Scholar 

  • Bhanji RA, Eystathioy T, Chan EK, Bloch DB, Fritzler MJ (2007) Clinical and serological features of patients with autoantibodies to GW/P bodies. Clin Immunol 125:247–256

    Article  PubMed  CAS  Google Scholar 

  • Calvani N, Satoh M, Croker BP, Reeves WH, Richards HB (2003) Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus. Kidney Int 64:897–905

    Article  PubMed  CAS  Google Scholar 

  • Ceribelli A, Tincani A, Cavazzana I, Franceschini F, Cattaneo R, Pauley BA, Chan JY, Chan EK, Satoh M (2011) Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). Autoimmunity 44:90–97

    Article  PubMed  CAS  Google Scholar 

  • Chan EK, Imai H, Hamel JC, Tan EM (1991) Human autoantibody to RNA polymerase I transcription factor hUBF. Molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor. J Exp Med 174:1239–1244

    Article  PubMed  CAS  Google Scholar 

  • Chan JYF, Yoshida H, Mizutani A, Yamasaki Y, Sobel ES, Chan EKL, Reeves WH, Satoh M (2009) Autoantibodies to RNA helicase A as a new serologic marker of early SLE. In: Conrad K, Chan EKL, Fritzler MJ, Sack U, Shoenfeld Y, Wiik A (eds) From etiopathogenesis to the prediction of autoimmune diseases: relevance of autoantibodies. Autoantigens, autoantibodies and autoimmunity. Proceedings 9th Dresden Symposium on Autoantibodies. Pabst Science Publishers, Lengerich, pp 61–70

    Google Scholar 

  • Dong X, Hamilton KJ, Satoh M, Wang J, Reeves WH (1994) Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen. J Exp Med 179:1243–1252

    Article  PubMed  CAS  Google Scholar 

  • Eystathioy T, Chan EK, Tenenbaum SA, Keene JD, Griffith K, Fritzler MJ (2002) A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol Biol Cell 13:1338–1351

    Article  PubMed  CAS  Google Scholar 

  • Fritzler MJ, Hamel JC, Ochs RL, Chan EK (1993) Molecular characterization of two human autoantigens: unique cDNAs encoding 95- and 160-kD proteins of a putative family in the Golgi complex. J Exp Med 178:49–62

    Article  PubMed  CAS  Google Scholar 

  • Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ (1985) Antinuclear, anticytoplasmic, and anti-Sjogren’s syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol 36:120–128

    Article  PubMed  CAS  Google Scholar 

  • Hamilton KJ, Satoh M, Swartz J, Richards HB, Reeves WH (1998) Influence of microbial stimulation on hypergammaglobulinemia and autoantibody production in pristane-induced lupus. Clin Immunol Immunopathol 86:271–279

    Article  PubMed  CAS  Google Scholar 

  • Jakymiw A, Ikeda K, Fritzler MJ, Reeves WH, Satoh M, Chan EK (2006) Autoimmune targeting of key components of RNA interference. Arthritis Res Ther 8:R87

    Article  PubMed  Google Scholar 

  • Jakymiw A, Lian S, Eystathioy T, Li S, Satoh M, Hamel JC, Fritzler MJ, Chan EK (2005) Disruption of GW bodies impairs mammalian RNA interference. Nat Cell Biol 7:1267–1274

    Article  PubMed  Google Scholar 

  • Ji J, Glaser A, Wernli M, Berke JM, Moradpour D, Erb P (2008) Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virus. J Gen Virol 89:2761–2766

    Article  PubMed  CAS  Google Scholar 

  • Kaburaki J, Hayakawa M, Tojo T (1984) Clinical aspects of antinuclear antibodies. Sceroderma. Immunol Dis 7:749–753

    Google Scholar 

  • Lee PY, Kumagai Y, Li Y, Takeuchi O, Yoshida H, Weinstein J, Kellner ES, Nacionales D, Barker T, Kelly-Scumpia K, van Rooijen N, Kumar H, Kawai T, Satoh M, Akira S, Reeves WH (2008) TLR7-dependent and Fc{gamma}R-independent production of type I interferon in experimental mouse lupus. J Exp Med 205:2995–3006

    Article  PubMed  CAS  Google Scholar 

  • Miyachi K, Hosaka H, Nakamura N, Miyakawa H, Mimori T, Shibata M, Matsushima S, Chinoh H, Horigome T, Hankins RW, Zhang M, Fritzler MJ (2006) Anti-p97/VCP antibodies: an autoantibody marker for a subset of primary biliary cirrhosis patients with milder disease? Scand J Immunol 63:376–382

    Article  PubMed  CAS  Google Scholar 

  • Mizutani A, Shaheen VM, Yoshida H, Akaogi J, Kuroda Y, Nacionales DC, Yamasaki Y, Hirakata M, Ono N, Reeves WH, Satoh M (2005) Pristane-induced autoimmunity in germ-free mice. Clin Immunol 114:110–118

    Article  PubMed  CAS  Google Scholar 

  • Nacionales DC, Kelly-Scumpia KM, Lee PY, Weinstein JS, Lyons R, Sobel E, Satoh M, Reeves WH (2007) Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis Rheum 56:3770–3783

    Article  PubMed  CAS  Google Scholar 

  • Onodera H (1986) A new precipitating antibody to the microsomal fraction in patients with connective tissue diseases. Okayama Igakkai Zasshi (J Okayama Med Assoc) 98:747–758

    Google Scholar 

  • Reeves WH, Narain S, Satoh M (2005) Autoantibodies in systemic lupus erythematosus. In: Koopman WJ, Moreland LW (eds) Arthritis and allied conditions. A textbook of rheumatology, 5th edn. Lippincott Williams and Wilkins, Philadelphia, pp 1497–1521

    Google Scholar 

  • Richards HB, Satoh M, Jennete JC, Croker BP, Yoshida H, Reeves WH (2001) Interferon g is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. Kidney Int 60:2173–2180

    Article  PubMed  CAS  Google Scholar 

  • Richards HB, Satoh M, Shaw M, Libert C, Poli V, Reeves WH (1998) Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J Exp Med 188:985–990

    Article  PubMed  CAS  Google Scholar 

  • Satoh M, Chan EK, Ho LA, Rose KM, Parks CG, Cohn RD, Jusko TA, Walker NJ, Germolec DR, Whitt IZ, Crockett PW, Pauley BA, Chan JY, Ross SJ, Birnbaum LS, Zeldin DC, Miller FW (2012) Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 64:2319–2327

    Article  PubMed  Google Scholar 

  • Satoh M, Chan EKL, Sobel ES, Kimpel DL, Yamasaki Y, Narain S, Mansoor R, Reeves WH (2007) Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev Clin Immunol 3:721–738

    Article  PubMed  CAS  Google Scholar 

  • Satoh M, Langdon JJ, Chou CH, McCauliffe DP, Treadwell EL, Ogasawara T, Hirakata M, Suwa A, Cohen PL, Eisenberg RA, Reeves WH (1994) Characterization of the Su antigen, a macromolecular complex of 100/102 and 200 kDa proteins recognized by autoantibodies in systemic rheumatic diseases. Clin Immunol Immunopathol 73:132–141

    Article  PubMed  CAS  Google Scholar 

  • Satoh M, Reeves WH (1994) Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 180:2341–2346

    Article  PubMed  CAS  Google Scholar 

  • Satoh M, Richards HB, Shaheen VM, Yoshida H, Shaw M, Naim JO, Wooley PH, Reeves WH (2000) Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin Exp Immunol 121:399–405

    Article  PubMed  CAS  Google Scholar 

  • Satoh M, Treadwell EL, Reeves WH (1995) Pristane induces high levels of anti-Su and anti-nRNP/Sm autoantibodies in BALB/c mice. Quantitation by antigen capture ELISAs based on monospecific human autoimmune sera. J Immunol Methods 182:51–62

    Article  PubMed  CAS  Google Scholar 

  • Tan EM (1982) Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol 33:167–240

    Article  PubMed  CAS  Google Scholar 

  • Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93–151

    Article  PubMed  CAS  Google Scholar 

  • Treadwell EL, Alspaugh MA, Sharp GC (1984) Characterization of a new antigen-antibody system(Su) in patients with systemic lupus erythematosus. Arthritis Rheum 27:1263–1271

    Article  PubMed  CAS  Google Scholar 

  • Treadwell EL, Cohen P, Williams D, O’Brien K, Volkman A, Eisenberg R (1993) MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus. J Immunol 150:695–699

    PubMed  CAS  Google Scholar 

  • Treadwell EL, Muller UR, Volkman A (1991) Extraction and differentiation of the Su autoantigen from calf thymus nuclei. J Immunol Methods 142:157–167

    Article  PubMed  CAS  Google Scholar 

  • Vazquez-Del Mercado M, Palafox-Sanchez CA, Munoz-Valle JF, Orozco-Barocio G, Oregon-Romero E, Navarro-Hernandez RE, Salazar-Paramo M, Armendariz-Borunda J, Gamez-Nava JI, Gonzalez-Lopez L, Chan JY, Chan EK, Satoh M (2010a) High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosus. Arthritis Res Ther 12:R6

    Article  PubMed  Google Scholar 

  • Vazquez-Del Mercado M, Sanchez-Orozco LV, Pauley BA, Chan JY, Chan EK, Panduro A, Maldonado Gonzalez M, Jimenez-Luevanos MA, Martin-Marquez BT, Palafox-Sanchez CA, Davalos-Rodriguez IP, Salazar-Paramo M, Gonzalez-Lopez L, Gamez-Nava JI, Satoh M (2010b) Autoantibodies to a miRNA-binding protein Argonaute2 (Su antigen) in patients with hepatitis C virus infection. Clin Exp Rheumatol 28:842–848

    PubMed  CAS  Google Scholar 

  • Wang J, Satoh M, Kabir F, Shaw M, Domingo MA, Mansoor R, Behney KM, Dong X, Lahita RG, Richards HB, Reeves WH (2001) Increased prevalence of autoantibodies to ku antigen in African American versus white patients with systemic lupus erythematosus. Arthritis Rheum 44:2367–2370

    Article  PubMed  CAS  Google Scholar 

  • Yoshida H, Satoh M, Behney KM, Lee C-G, Richards HB, Shaheen VM, Yang JQ, Singh RR, Reeves WH (2002) Effect of an exogenous trigger on the pathogenesis of lupus in NZB x NZW (F1) mice. Arthritis Rheum 46:2235–2244

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Minoru Satoh .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Satoh, M., Chan, J.Y.F., Ceribelli, A., del-Mercado, M.V., Chan, E.K.L. (2013). Autoantibodies to Argonaute 2 (Su Antigen). In: Chan, E., Fritzler, M. (eds) Ten Years of Progress in GW/P Body Research. Advances in Experimental Medicine and Biology, vol 768. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5107-5_4

Download citation

Publish with us

Policies and ethics